As of 2026-09-14, the EV/EBITDA ratio of Marinus Pharmaceuticals Inc (MRNS) is -0.36. EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. MRNS's latest enterprise value is 43.38 mil USD. MRNS's TTM EBITDA according to its financial statements is -121.83 mil USD. Dividing these 2 quantities gives us the above MRNS EV/EBITDA ratio.
Note: valuation result may not be accurate due to the company's negative EBITDA.
| Range | Selected | |
| Trailing P/E multiples | 7.7x - 8.5x | 8.2x |
| Forward P/E multiples | 14.9x - 17.1x | 16.5x |
| Fair Price | (33.15) - (18.90) | (27.37) |
| Upside | -6127.7% - -3536.4% | -5076.7% |
| Date | EV/EBITDA |